WHO ICTRP trial
A Bioequivalence study of a randomized, open-label, single dose, two-way…
TCTR20240427005 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20240427005 |
|---|---|
| Public title | A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Venlafaxine Prolonged -release Capsules BP 150 mg to Originator in healthy Thai volunteers under fasting condition |
| Scientific title | A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Venlafaxine Prolonged -release Capsules BP 150 mg to Originator in healthy Thai volunteers under fasting condition |
| Primary sponsor | Bio-innova Co., Ltd. |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Thailand |
| Conditions | Healthy subjects Bioequivalence Venlafaxine Prolonged-release Capsules BP 150 mg ;Bioequivalence Venlafaxine Prolonged-release Capsules BP 150 mg |
| Interventions | The new generic products which were recently developed. Volunteer will receive a single dose of Venlafaxine Prolonged -release Capsules BP 150 mg of either test or reference with 240 mL of drinking water.,The marketed original products… |
| Registration date | Apr 27, 2024 |
| Target size | 28 |
| Secondary IDs | Nil Known |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: